{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05410145",
            "orgStudyIdInfo": {
                "id": "D3S-001-100"
            },
            "secondaryIdInfos": [
                {
                    "id": "2023-508517-16",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "D3 Bio (Wuxi) Co., Ltd",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of D3S 001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation",
            "officialTitle": "A Phase 1/2, Open Label, Dose-escalation, and Dose-expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of D3S 001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-of-monotherapy-or-combination-therapy-in-subjects-with-advanced-solid-tumors-with-a-kras-p-mutation"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-08-03",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-09",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-05-25",
            "studyFirstSubmitQcDate": "2022-06-06",
            "studyFirstPostDateStruct": {
                "date": "2022-06-08",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-30",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "D3 Bio (Wuxi) Co., Ltd",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a first-in-human (FIH), multicenter, open-label, dose-escalation, and dose-expansion Phase 1/2 clinical trial to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of D3S-001 or combination therapy in subjects with advanced KRAS p.G12C mutant solid tumors. D3S-001 will be taken daily by oral administration in 21-day treatment cycles."
        },
        "conditionsModule": {
            "conditions": [
                "KRAS P.G12C"
            ],
            "keywords": [
                "KRAS p.G12C",
                "Mutation",
                "advanced solid tumors"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 352,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "D3S-001 monotherapy",
                    "type": "EXPERIMENTAL",
                    "description": "Part 1: Dose Escalation, D3S-001 administered orally.\n\nPart 2 and Part 3a Arm C: Dose Expansion, D3S-001 administered orally in selected cancer type patients.",
                    "interventionNames": [
                        "Drug: D3S-001"
                    ]
                },
                {
                    "label": "D3S-001 and pembrolizumab",
                    "type": "EXPERIMENTAL",
                    "description": "Part 3a Arm A: Dose Expansion, D3S-001 in combination therapy administered orally in selected cancer type patients.\n\nPembrolizumab administered intravenously.",
                    "interventionNames": [
                        "Drug: D3S-001",
                        "Drug: Pembrolizumab"
                    ]
                },
                {
                    "label": "D3S-001 and platinum doublet chemotherapy (cisplatin + pemetrexed or carboplatin + permetrexed)",
                    "type": "EXPERIMENTAL",
                    "description": "Part 3a Arm B: Dose Expansion, D3S-001 in combination therapy administered orally in selected cancer type patients.\n\nCisplatin + pemetrexed administered intravenously\n\nor\n\nCarboplatin + permetrexed administered intravenously",
                    "interventionNames": [
                        "Drug: D3S-001",
                        "Drug: Cisplatin",
                        "Drug: Carboplatin",
                        "Drug: Pemetrexed"
                    ]
                },
                {
                    "label": "D3S-001 and Cetuximab",
                    "type": "EXPERIMENTAL",
                    "description": "Part 3b: Dose Expansion, D3S-001 in combination therapy administered orally in selected cancer type patients.\n\nCetuximab administered intravenously.",
                    "interventionNames": [
                        "Drug: D3S-001",
                        "Drug: Cetuximab"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "D3S-001",
                    "description": "Oral",
                    "armGroupLabels": [
                        "D3S-001 and Cetuximab",
                        "D3S-001 and pembrolizumab",
                        "D3S-001 and platinum doublet chemotherapy (cisplatin + pemetrexed or carboplatin + permetrexed)",
                        "D3S-001 monotherapy"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Pembrolizumab",
                    "description": "Intravenous",
                    "armGroupLabels": [
                        "D3S-001 and pembrolizumab"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Cisplatin",
                    "description": "Intravenous",
                    "armGroupLabels": [
                        "D3S-001 and platinum doublet chemotherapy (cisplatin + pemetrexed or carboplatin + permetrexed)"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Carboplatin",
                    "description": "Intravenous",
                    "armGroupLabels": [
                        "D3S-001 and platinum doublet chemotherapy (cisplatin + pemetrexed or carboplatin + permetrexed)"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Pemetrexed",
                    "description": "Intravenous",
                    "armGroupLabels": [
                        "D3S-001 and platinum doublet chemotherapy (cisplatin + pemetrexed or carboplatin + permetrexed)"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Cetuximab",
                    "description": "Intravenous",
                    "armGroupLabels": [
                        "D3S-001 and Cetuximab"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of Participants With Adverse Events (AEs)",
                    "timeFrame": "From first dose until 30 days after the last dose (or specified in the protocol)."
                },
                {
                    "measure": "Number of Participants With Dose-Limiting Toxicities (DLTs)",
                    "timeFrame": "From Cycle 1 Day 1 through Day 21. Each cycle is 21 days."
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "D3S-001 maximum observed plasma concentration (Cmax)",
                    "timeFrame": "Up to 24 months."
                },
                {
                    "measure": "D3S-001 time to maximum plasma concentration (tmax)",
                    "timeFrame": "Up to 24 months."
                },
                {
                    "measure": "D3S-001 half-life (t1/2)",
                    "timeFrame": "Up to 24 months."
                },
                {
                    "measure": "D3S-001 area under the concentration-time curve (AUC)",
                    "timeFrame": "Up to 24 months."
                },
                {
                    "measure": "Objective response rate (ORR) as Determined by the Investigator According to Response Evaluation Criteria in Solid Tumors, Version 1.1 (RECIST v1.1)",
                    "timeFrame": "Up to 24 months."
                },
                {
                    "measure": "Duration of Response (DOR) as Determined by the Investigator According to Response Evaluation Criteria in Solid Tumors, Version 1.1 (RECIST v1.1)",
                    "timeFrame": "Up to 24 months."
                },
                {
                    "measure": "Progression-free survival (PFS) as determined by the investigator according to Response Evaluation Criteria in Solid Tumors, Version 1.1 (RECIST v1.1)",
                    "timeFrame": "Up to 24 months."
                },
                {
                    "measure": "Disease Control Rate (DCR) as Determined by the Investigator According to Response Evaluation Criteria in Solid Tumors, Version 1.1 (RECIST v1.1)",
                    "timeFrame": "Up to 24 months."
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion:\n\n* Subject must have a histologically or cytologically confirmed metastatic or locally advanced solid tumor which is progressing.\n* Subject must have documented KRAS p.G12C mutation identified within the last 5 years by a local test on tumor tissue or blood.\n* Subject must have measurable disease per RECIST v1.1.\n* Subject must have Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.\n* Subject must have adequate organ and marrow function within the screening period.\n\nExclusion:\n\n* Subject has any prior treatment with other treatments without adequate washout periods as defined in the protocol.\n* Subject has uncontrolled intercurrent illness, including but not limited to, ongoing or active infection, uncontrolled or significant cardiovascular disease, serious chronic gastrointestinal conditions associated with diarrhea, or psychiatric illness/social situations that would limit compliance with study requirements, substantially increase risk of incurring AEs, or compromise the ability of the subject to give written informed consent.\n* Subject has unresolved treatment-related toxicities from previous anticancer therapy of NCI CTCAE Grade \u22652 (with exception of vitiligo or alopecia).\n* Subject has active gastrointestinal disease or other that could interfere significantly with the absorption, distribution, metabolism, or excretion of oral therapy.\n* Concurrent participation in any clinical research study involving treatment with any investigational drug, radiotherapy, or surgery, except for the nontreatment phases of these studies (e.g., follow-up phase).\n\nOther protocol inclusion/exclusion criteria may apply",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Medical Director",
                    "role": "CONTACT",
                    "phone": "+86 21 61635900",
                    "email": "D3bio_CT@d3bio.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Cheng Chen, MD",
                    "affiliation": "D3 Bio (Wuxi) Co., Ltd",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Orange",
                    "state": "California",
                    "zip": "92868",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.78779,
                        "lon": -117.85311
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Denver",
                    "state": "Colorado",
                    "zip": "80218-1238",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.73915,
                        "lon": -104.9847
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Sarasota",
                    "state": "Florida",
                    "zip": "34232-6410",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.33643,
                        "lon": -82.53065
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Detroit",
                    "state": "Michigan",
                    "zip": "48202-2608",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.33143,
                        "lon": -83.04575
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37203",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Sydney",
                    "state": "New South Wales",
                    "zip": "2109",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -33.86785,
                        "lon": 151.20732
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Malvern",
                    "state": "Victoria",
                    "zip": "3144",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -32.02849,
                        "lon": 151.32225
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Nedlands",
                    "state": "Western Australia",
                    "zip": "6009",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -31.98184,
                        "lon": 115.8073
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Beijing",
                    "state": "Beijing",
                    "zip": "100036",
                    "country": "China",
                    "geoPoint": {
                        "lat": 39.9075,
                        "lon": 116.39723
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Guangzhou",
                    "state": "Guangdong",
                    "zip": "510120",
                    "country": "China",
                    "geoPoint": {
                        "lat": 23.11667,
                        "lon": 113.25
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Hangzhou",
                    "state": "Hangzhou",
                    "zip": "310022",
                    "country": "China",
                    "geoPoint": {
                        "lat": 30.29365,
                        "lon": 120.16142
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Harbin",
                    "state": "Heilongjiang",
                    "zip": "150081",
                    "country": "China",
                    "geoPoint": {
                        "lat": 45.75,
                        "lon": 126.65
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Wuhan",
                    "state": "Hubei",
                    "zip": "43000",
                    "country": "China",
                    "geoPoint": {
                        "lat": 30.58333,
                        "lon": 114.26667
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Wuhan",
                    "state": "Hubei",
                    "zip": "430079",
                    "country": "China",
                    "geoPoint": {
                        "lat": 30.58333,
                        "lon": 114.26667
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Nanchang",
                    "state": "Jiangxi",
                    "zip": "330008",
                    "country": "China",
                    "geoPoint": {
                        "lat": 28.68396,
                        "lon": 115.85306
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Shenyang",
                    "state": "Liaoning",
                    "zip": "110042",
                    "country": "China",
                    "geoPoint": {
                        "lat": 41.79222,
                        "lon": 123.43278
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Jinan",
                    "state": "Shandong",
                    "zip": "250117",
                    "country": "China",
                    "geoPoint": {
                        "lat": 36.66833,
                        "lon": 116.99722
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Shanghai",
                    "state": "Shanghai",
                    "zip": "200030",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Shanghai",
                    "state": "Shanghai",
                    "zip": "201801",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Hangzhou",
                    "state": "Zhejiang",
                    "zip": "310003",
                    "country": "China",
                    "geoPoint": {
                        "lat": 30.29365,
                        "lon": 120.16142
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Sha Tin",
                    "zip": "999077",
                    "country": "Hong Kong",
                    "geoPoint": {
                        "lat": 22.38333,
                        "lon": 114.18333
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Cheongju-si",
                    "state": "North Chungcheong",
                    "zip": "28644",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 36.63722,
                        "lon": 127.48972
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "06591",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "120-752",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "D3 Bio Investigative Site",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "138-736",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000016190",
                    "term": "Carboplatin"
                },
                {
                    "id": "C000582435",
                    "term": "Pembrolizumab"
                },
                {
                    "id": "D000068437",
                    "term": "Pemetrexed"
                },
                {
                    "id": "D000068818",
                    "term": "Cetuximab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000082082",
                    "term": "Immune Checkpoint Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000005493",
                    "term": "Folic Acid Antagonists"
                },
                {
                    "id": "D000019384",
                    "term": "Nucleic Acid Synthesis Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M18650",
                    "name": "Carboplatin",
                    "asFound": "System",
                    "relevance": "HIGH"
                },
                {
                    "id": "M349416",
                    "name": "Pembrolizumab",
                    "asFound": "Mg/m2",
                    "relevance": "HIGH"
                },
                {
                    "id": "M264",
                    "name": "Pemetrexed",
                    "asFound": "Target",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6182",
                    "name": "Cisplatin",
                    "relevance": "LOW"
                },
                {
                    "id": "M315",
                    "name": "Cetuximab",
                    "asFound": "Physician",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M2342",
                    "name": "Immune Checkpoint Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M17546",
                    "name": "Vitamin B Complex",
                    "relevance": "LOW"
                },
                {
                    "id": "M8618",
                    "name": "Folic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "M8619",
                    "name": "Folic Acid Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "T446",
                    "name": "Folic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "T447",
                    "name": "Folinic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "T448",
                    "name": "Folate",
                    "relevance": "LOW"
                },
                {
                    "id": "T475",
                    "name": "Vitamin B9",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Micro",
                    "name": "Micronutrients"
                },
                {
                    "abbrev": "Hemat",
                    "name": "Hematinics"
                },
                {
                    "abbrev": "Vi",
                    "name": "Vitamins"
                }
            ]
        }
    },
    "hasResults": false
}